JP Morgan Chase’s Semler Scientific SMLR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9,686
| Closed | -$148K | – | 7858 |
|
|
2025
Q4 | $148K | Buy |
9,686
+4,744
| +96% | +$108K | ﹤0.01% | 5678 |
|
|
2025
Q3 | $148K | Buy |
4,942
+799
| +19% | +$27.5K | ﹤0.01% | 5682 |
|
|
2025
Q2 | $161K | Buy |
4,143
+776
| +23% | +$27.7K | ﹤0.01% | 5356 |
|
|
2025
Q1 | $122K | Buy |
3,367
+1,043
| +45% | +$48.9K | ﹤0.01% | 5471 |
|
|
2024
Q4 | $125K | Buy |
2,324
+142
| +7% | +$6.52K | ﹤0.01% | 5666 |
|
|
2024
Q3 | $51.4K | Sell |
2,182
-103
| -5% | -$2.96K | ﹤0.01% | 5978 |
|
|
2024
Q2 | $78.6K | Sell |
2,285
-27,553
| -92% | -$794K | ﹤0.01% | 5650 |
|
|
2024
Q1 | $872K | Buy |
29,838
+9,537
| +47% | +$398K | ﹤0.01% | 4446 |
|
|
2023
Q4 | $899K | Buy |
20,301
+17,059
| +526% | +$613K | ﹤0.01% | 4398 |
|
|
2023
Q3 | $82.3K | Sell |
3,242
-3,171
| -49% | -$82.5K | ﹤0.01% | 5603 |
|
|
2023
Q2 | $168K | Buy |
6,413
+4,439
| +225% | +$117K | ﹤0.01% | 5176 |
|
|
2023
Q1 | $53K | Buy |
+1,974
| New | +$55.3K | ﹤0.01% | 5679 |
|
|
2022
Q4 | – | Sell |
-4,134
| Closed | -$155K | – | 6962 |
|
|
2022
Q3 | $155K | Buy |
+4,134
| New | +$156K | ﹤0.01% | 5066 |
|
JP Morgan Chase's SMLR Position: Q1 2026 in Review
JP Morgan Chase sold out of Semler Scientific (SMLR) in Q1 2026, closing a stake of 9,686 shares — an estimated $148K sold.
JP Morgan Chase first reported a position in SMLR in Q3 2022 and held it in 13 quarters. The position peaked at $899K in Q4 2023. 0 funds tracked by Wall St. Rank hold SMLR as of Q1 2026.
- JP Morgan Chase reported no remaining Semler Scientific position as of Q1 2026 after selling out during the quarter.
- JP Morgan Chase sold 9,686 Semler Scientific shares in Q1 2026, an estimated $148K.
- JP Morgan Chase first reported a position in Semler Scientific in Q3 2022 and held it in 13 quarters.
- JP Morgan Chase's Semler Scientific position peaked at $899K in Q4 2023.
- 0 funds tracked by Wall St. Rank held Semler Scientific as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.